(Q47625816)

4 February 2018

title

Antihyperalgesic effects of spinal cannabinoids. (English)

1 reference

4 February 2018

0 references

J D Richardson

1

1 reference

4 February 2018

L Aanonsen

series ordinal

2

1 reference

4 February 2018

K M Hargreaves

series ordinal

3

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

4 February 2018

European Journal of Pharmacology

published in

1 reference

4 February 2018

volume

345

1 reference

4 February 2018

page(s)

145-153

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Intrathecal morphine in mice: a new technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901621-X

10.1016/S0014-2999(97)01621-X

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9600630

1 reference

4 February 2018